(September 7, 2005) -- Boston Scientific Corporation (NYSE: BSX) today commented on its third quarter performance. Speaking at the 2005 Thomas Weisel Partners Healthcare Conference in Boston, Larry Best, Boston Scientific Chief Financial Officer, said that third quarter results to date have been soft compared to expectations and that revenues and earnings for the quarter are unlikely to reach the levels on which previous guidance for the quarter had been based.

“Although the third quarter looks soft, we remain hopeful that we will meet our guidance for the year on revenues and earnings,